PETERS WILLIAM J 4
4 · Amphastar Pharmaceuticals, Inc. · Filed Aug 2, 2024
Insider Transaction Report
Form 4
PETERS WILLIAM J
DirectorCFO, EVP & TREASURER
Transactions
- Exercise/Conversion
Common Stock
2024-07-31$20.23/sh+10,282$208,005→ 104,385 total - Sale
Common Stock
2024-07-31$44.23/sh−10,282$454,773→ 94,103 total - Exercise/Conversion
Employee Stock Option (right to buy)
2024-07-31−10,282→ 4,943 totalExercise: $20.23Exp: 2029-03-15→ Common Stock (10,282 underlying)
Footnotes (2)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2024.
- [F2]Shares subject to the option are fully vested and immediately exercisable.